Lekamwasam, S., Adachi, J.D., Agnusdei, D., Bilezikian, J., Boonen, S., Borgström, F., et al. (2012) A Framework for the Development of Guidelines for the Management of Glucocorticoid-Induced Osteoporosis. Osteoporosis International, 23, 2257-2276.
https://doi.org/10.1007/s00198-012-1958-1

has been cited by the following article:

• TITLE: Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  AUTHORS: IsraaIsraa Ahmed Radwan, Nahed Sedky Korany, Bassant Adel Ezzat

  KEYWORDS: Bisphosphonates, Alendronate, Zoledronate, Postmenopausal Osteoporosis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.5, May 10, 2018

  ABSTRACT: Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.